Phase 1 - National practice questionnaire of impalpable breast lesion localisations

Magseed is a new breast localisation technique for excision of impalpable lesions. The iBRA-net study of Magseed aims to:

·         Describe the current practice of breast localisations.

·         Evaluate the outcomes of Magseed localisation.

·         Inform a potential trial in breast localisation surgery.

The study will be conducted in the following phases:

1)      Phase 1 - National practice questionnaire survey of current breast localisation techniques in individual breast units.

2)      Phase 2 – Prospective audits

          a. Local audit of the outcomes of current breast localisation method.

          b. Local audit of Magseed breast localisations.

It is hoped that the study will create high quality data that will help surgeons, radiologists, managers and patients make more informed decisions about their localisation technique. It is also designed to disseminate early learning points to optimise safe and effective use of the technology.

As part of Phase I of the study, we welcome you to complete this National practice questionnaire of breast localisations on behalf of your breast unit. Please submit only one survey from your unit. This should not take more than 5 minutes and we would really appreciate your time and input.

Question Title

* 1. I am a

Question Title

* 2. Which breast unit do you represent?

Question Title

* 3. Please state region

Question Title

* 5. What technique/s are you using as your current standard practice for localisation of impalpable breast lesions? (Click all applicable)

Question Title

* 6. How many localisations are done in your breast unit per year?

Question Title

* 7. Who performs the localisation? (Click all applicable)

Question Title

* 9. If you have answered 'No' to the above question, where do your patients have their stereotactic localisations done? Please state site.

Question Title

* 10. When do patients have their preoperative localisation?

Question Title

* 11. Following localisation, where does the patient’s surgery happen?

Question Title

* 12. How do they travel from radiology suite to their operation?

Question Title

* 13. If the localisation is done on the same day as the surgery without sentinel lymph node (SLN) injection, what is the average time from arrival in the radiology suite to being ready to be anaesthetised?

Question Title

* 14. If the localisation is performed on the same day as the surgery and the patient does not require SLN injection, what time can the first localisation guided surgery be scheduled?

Question Title

* 15. If patient needs a sentinel lymph node biopsy (SLNB), when is the SLN injection performed?

Question Title

* 16. Where is the SLN injection performed?

Question Title

* 17. If  the breast localisation and SLN injection are done on the same day as surgery, what is the additional time required for SLN localisation?

Question Title

* 18. Are there ever any delays in theatre due to waiting for localisation patients?

Question Title

* 19. Does the list ever overrun due to delays in localisations?

Question Title

* 20. How satisfied are you with your current localisation technique/s? (0 - least satisfied, 10 - most satisfied)

0 5 10
i We adjusted the number you entered based on the slider’s scale.

Question Title

* 21. What concerns do you have about about your current localisation technique? Click all applicable

Question Title

* 23. If you have answered 'Yes' to the above question, what improvements would you like to see?

Question Title

* 24. What are your concerns / barriers to change to a new localisation technique?

Question Title

* 25. If you have trialled Magseed, how many have you done?

Question Title

* 26. Would you be interested in participating in Phase 2a and Phase 2b of this study? (Please see introduction)

Question Title

* 27. If Yes, please provide contact details

T